Q32 Bio Inc. (QTTB) Cash from Investing Activities (2017 - 2025)

Q32 Bio has reported Cash from Investing Activities for 9 years, with the latest figure at $7.0 million in Q4 2025.

• On a quarterly basis, Cash from Investing Activities rose 350100.0% year-over-year to $7.0 million in Q4 2025; TTM through Jun 2026 was $7.0 million, a 29.58% decrease from a year earlier, with the FY2025 full-year figure at $7.0 million, down 64.87% from the prior year.
• Cash from Investing Activities was $7.0 million for Q4 2025 at Q32 Bio, up from -$2000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $168.3 million in Q1 2022, with the low at -$108.2 million in Q3 2022.
• Average Cash from Investing Activities over 5 years is $803000.0, with a median of $49000.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities slumped 2492.09% in 2022, then jumped 994300.0% in 2024.
• Over 5 years, Cash from Investing Activities stood at $43.7 million in 2021, then slumped by 58.79% to $18.0 million in 2022, then slumped by 100.01% to -$1000.0 in 2023, then sank by 100.0% to -$2000.0 in 2024, then surged by 350100.0% to $7.0 million in 2025.
• The last three Cash from Investing Activities figures came in at $7.0 million (Q4 2025), -$2000.0 (Q4 2024), and $9.9 million (Q3 2024), per Business Quant data.